my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Silence Therapeutics plc announced the creation of a Scientific Advisory Board (SAB) with the appointment of two Key Opinion Leaders (KOLs) in the area of liver disease, Professor Dr. Dr. Detlef Schuppan, M.D., PhD., and Professor Dr. Massimo Pinzani, M.D., PhD., F.R.C.P. The SAB will provide scient more
Mucosis B.V. announced that it has appointed professors Jiri Mestecky, M.D., Ph.D.; Willem van Eden, M.D., Ph.D.; and Peter J. Openshaw, M.B., B.S., Ph.D., F.Med.Sci., to its newly formed Scientific Advisory Board.Dr. Mestecky is with the Department of Microbiology and Medicine at the University of more
Prosonix announced the appointment of a new Scientific Advisory Board. The new SAB comprises internationally renowned scientific, regulatory and clinical advisors who will act as both key collaborators and advocates for the business in the global pharmaceutical arena.The SAB will be chaired by Dr Ke more
Paul Billings speaks to Tarryn Greenberg, Managing Commissioning Editor Board certified internist and clinical geneticist Dr Paul R Billings serves as Chief Medical Officer of Life Technologies Corporation, a new position aimed at improving patient care through expanding the use of medically relevan more
In this Perspective, I review my scientific career, which began after I trained in medicine in Montreal and in neurology in Boston. I started in immunology in London with Avrion Mitchison, using antibodies against cell-surface antigens to study the development and functions of mouse T and B cells. T more
CardioGenics Holdings Inc. (CardioGenics) is a publicly held company engaged in the development of technology and products, which are utilized in the immunoassay segment of the in-vitro diagnostic markets. The company's major product, QL Care Analyzer is a point of care immuno-analyzer that would be more
Pluristem Therapeutics Inc. (Pluristem) is a bio-therapeutics company that is engaged in the development and commercialization of cell therapy production technologies and products. It mainly focuses on commercialization of non-personalized (allogeneic) cell therapy products for the treatment of seve more
A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Fully human antibodies for any target 4-Antibody’s proprie more
Skip to content About Amylin Our Story Our Culture Leadership & Structure Management Team Board of Directors Strategic Partners Advisory Boards Contact Us Products SYMLIN ® (pramlintide acetate) injection BYETTA ® (exenatide) injection Patient Stories Patient Resources Patient Assistance Program more
Home About Us Company History Management Brochure (pdf) Pipeline Cancer Drug Programmes Chk1 FLT4 Aurora FLT3 PLK B-raf FASN Partnering Research Services Out-licensing Investors Board of Directors Information Disclosure Investor News Company Advisors Research News & Events Press Release Publications more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
